Medtronic plc.
MDT Large CapHealthcare · Medical Devices
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Medtronic plc. en bref
Medtronic plc. (MDT) is currently trading at 69,15 € with a market capitalization of 88,8 Md €. The trailing P/E ratio stands at 21.04x, with a forward P/E of 12.38x. The 52-week range spans from 63,91 € to 92,69 €; the current price is 25.4% below the yearly high. Year-over-year revenue growth stands at +9.9%. The net profit margin stands at 13.2%.
💰 Dividende
Medtronic plc. pays an annual dividend of 2,51 € per share, representing a yield of 3.63%. The payout ratio stands at 76.14%.
📊 Avis des analystes
26 analystes évaluent Medtronic plc. (MDT) au consensus : Acheter. L'objectif de cours moyen est de 85,43 €, soit un potentiel de +23.55% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 68,00 € à 105,48 €.
Medtronic plc. : la thèse d'investissement en détail
Medtronic plc. (MDT) operates in the Healthcare — specifically Medical Devices — and is headquartered in Ireland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
With a gross margin near 65.38%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Wall Street consensus sits at Buy with an average price target implying roughly 23.55% upside from current levels — analyst sentiment is firmly constructive.
À surveiller
- The forward P/E of 12.38x is meaningfully below the trailing 21.04x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 23.55% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Marge brute élevée de 65.38% — signe d'un pouvoir de fixation des prix
- Consensus des analystes : Buy
- Rendement du dividende solide de 3.63%
Aucun signal d'alerte significatif dans les indicateurs actuels.
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
The data points to relatively defensive market behavior.
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Medtronic plc.?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
